Literature DB >> 3061333

Autoimmunity in demyelinating diseases.

B H Waksman1.   

Abstract

Demyelinative diseases of the CNS and peripheral nervous system can be distinguished on the basis of primary mediation by antibody or T lymphocytes (or failure of the T-cell-mediated response) and on the basis of chronicity. The principal mechanisms are autoimmunization to myelin antigens after actual immunization with tissue or infection with cross-reactive viruses or, alternatively, persistent infection of the nervous system (viral or spirochetal) with an associated immune response to the pathogen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061333     DOI: 10.1111/j.1749-6632.1988.tb27047.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  A 10-year matched-pairs study comparing azathioprine and no immunosuppression in multiple sclerosis.

Authors:  L Kappos; R Heun; H G Mertens
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

2.  Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region.

Authors:  M A Walter; W T Gibson; G C Ebers; D W Cox
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

Review 3.  Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.

Authors:  Stephen D Skaper
Journal:  Immunology       Date:  2017-02-21       Impact factor: 7.397

Review 4.  Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions.

Authors:  S D Skaper
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

5.  Dual expression of CD45RA and CD45RO isoforms on myelin basic protein-specific CD4+ T-cell lines in multiple sclerosis.

Authors:  Y Qin; S Van Den Noort; J Kurt; S Gupta
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a.

Authors:  Shlomo Flechter; Tirza Klein; Lea Pollak
Journal:  Neurol Int       Date:  2011-06-15

7.  Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.

Authors:  Borros Arneth
Journal:  J Transl Med       Date:  2015-11-02       Impact factor: 5.531

Review 8.  Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis.

Authors:  G L Stoner
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.